Sign in
Not yet taking people in United StatesNo phase

Testing a breathing mask for people with sleep apnea at home

Tests how well a face mask works at home for obstructive sleep apnea.

Key facts

Who runs it
Fisher and Paykel Healthcare
Where
Columbia, United StatesSee the site
Trial code
Registry title
Evaluation of F&P Mask, US, 2026
Status
Not yet recruiting
People taking part
45 people, planned
Started
26 Oct 2026
Expected to end
14 Jul 2027
Type of study
Interventional
Treatments tested
  • F&P Mask
Record updated
9 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who already use a PAP/NIV breathing mask at home, for example for sleep apnea. They will test the F&P mask at home.

Age
22 years or older
Sex
All sexes can join
Disease stage
People must have a doctor's prescription for PAP/NIV therapy (machine-assisted breathing). They must weigh 66 pounds (30 kg) or more.
Earlier treatment
People must have used a PAP/NIV mask for 3 months or more. In a 14-day period within the 30 days before joining, they must have used it at least 4 hours per night on at least 70% of nights.

Main reasons for not taking part

  • Body conditions that make PAP/NIV therapy unsafe or unhelpful
  • Needing PAP/NIV for more than 12 hours a day, or for long periods besides sleep or naps
  • Being pregnant, trying to get pregnant, or thinking you may be pregnant
  • IPAP pressure above 30 cmH2O on BPAP, or using the device to give medicines other than extra oxygen
  • A device that cannot record AHI and leak data that the trial site can see

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Are ≥22 years of age
  • Weigh ≥66 pounds
  • Have been prescribed PAP/NIV therapy by a physician
  • Are an existing PAPNIV mask user with ≥3 months of use prior to enrolment in the clinical investigation
  • Are compliant with PAP/NIV therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical investigation
  • Are fluent in spoken and written English
  • Possess the capacity to provide informed consent

Who cannot take part

  • Are required to use PAP/NIV therapy for >12 hours per day or for extensive periods, not including sleep or naps
  • Use a PAP/NIV therapy device for the delivery of medicines, except supplemental O2
  • Use a PAP/NIV therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the clinical investigation site
  • Possess, or suffer from, anatomical or physiological conditions which make PAP/NIV therapy inappropriate
  • Have a history of light-induced seizures (for optional anthropometric scan only)
  • Are trying to get pregnant, are pregnant, or think they may be pregnant
  • Have an IPAP pressure of >30 cmH2O if on BPAP

Where in United States

  • Bogan Sleep ConsultantsColumbia, United StatesContact: Angie HowardNot yet recruiting

About the trial

What the trial wants to find out

This clinical investigation is designed to validate and confirm the overall performance, safety, usability, reliability, and acceptability of the F\&P mask in a home environment.

The group in the trial

  • InterventionOther group

    Single-arm, non-randomised, open-label

    Treatment: F&P Mask

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of F&P Mask, US, 2026
Plain-language title
Testing a breathing mask for people with sleep apnea at homeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
9 October 2026